Sopharma AD Dividend
Dividend criteria checks 3/6
Sopharma AD is a dividend paying company with a current yield of 14.75%.
Key information
14.8%
Dividend yield
225%
Payout ratio
| Industry average yield | 2.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | лв0.57 |
| Dividend yield forecast in 3Y | 4.9% |
Recent dividend updates
Recent updates
Sopharma AD (BUL:SFA) Has A Somewhat Strained Balance Sheet
Apr 09
Here's Why We Think Sopharma AD (BUL:3JR) Is Well Worth Watching
Feb 20How Many Sopharma AD (BUL:3JR) Shares Do Institutions Own?
Feb 05Should You Rely On Sopharma AD's (BUL:3JR) Earnings Growth?
Jan 22Sopharma AD (BUL:3JR) Has A Somewhat Strained Balance Sheet
Jan 06
Sopharma AD (BUL:3JR) Share Prices Have Dropped 25% In The Last Three Years
Dec 22Should Sopharma AD (BUL:3JR) Be Part Of Your Dividend Portfolio?
Dec 07Are Investors Undervaluing Sopharma AD (BUL:3JR) By 29%?
Nov 19Should Sopharma AD (BUL:3JR) Be Part Of Your Dividend Portfolio?
Jul 07Stability and Growth of Payments
Fetching dividends data
Stable Dividend: SFA's dividend payments have been volatile in the past 10 years.
Growing Dividend: SFA's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Sopharma AD Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (SFA) | 14.8% |
| Market Bottom 25% (BG) | 1.1% |
| Market Top 25% (BG) | 6.7% |
| Industry Average (Pharmaceuticals) | 2.5% |
| Analyst forecast in 3 Years (SFA) | 4.9% |
Notable Dividend: SFA's dividend (14.75%) is higher than the bottom 25% of dividend payers in the BG market (1.19%).
High Dividend: SFA's dividend (14.75%) is in the top 25% of dividend payers in the BG market (6.65%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (224.7%), SFA's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (8537.2%), SFA's dividend payments are not well covered by cash flows.